The annual prevalence increased to 0.4% by 2022, with an estimated 854,728 adults without diabetes using GLP-1 RAs. HealthDay News — Among US adults without diabetes, the use of glucagon-like peptide ...
The drug that Jeremy Mitchell takes to manage his diabetes, Ozempic, has become a hot new weight loss fad, and now he’s having trouble finding it. Mitchell, 39, of El Dorado, Kansas, was diagnosed ...
DALLAS (CBSDFW.COM) — A number of companies who have produced Super Bowl ads for decades aren't doing it this year, but one Texas native and Grammy Award-nominated pop star is part of a campaign that ...
The cost of insulin remains a barrier for many Americans with diabetes who depend on the drug, research published Monday suggests. A study in the Annals of Internal Medicine found that in 2021, nearly ...
“Mark is a strategic, global leader with a successful track record of driving above market business growth, while building scalable commercial operations and delivering best-in-class customer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback